Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-03

FDA Approved: BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM — Supplemental Application (Alvogen Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Buprenorphine and Naloxone Sublingual Film by Alvogen Inc., enabling a new manufacturing/formulation for opioid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine and naloxone sublingual film (Buprenorphine and naloxone)

Snippet

SUPPL AP for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM (BUPRENORPHINE AND NALOXONE)